Family Psychoeducation for Children With Mood Disorders

Status Completed

Clinical Trial Summary

The purpose of this study is to evaluate the effectiveness of a Multifamily Psychoeducation Group for the families of children with mood disorders.

Clinical Trial Description

Mood disorders among youth are a major health concern. Existing mood disorder studies focus on adults, and studies that focus on effective intervention strategies for youth with mood disorders are needed. This 8-session study is an adjunct to ongoing medication management and individual and family psychotherapy for children with mood disorders.

In this study, parents learn about mood disorders, their treatments, and how to work effectively with mental health and school systems. Parents also practice problem-solving and communication skills for symptom management. Children learn about mood disorders and their treatments, including basic cognitive-behavioral principles. Children also learn and practice anger management, problem-solving, and communication skills.

Patients and their families are randomly assigned to 1 of 2 groups. The first group receives 8 sessions of psychoeducation plus treatment as usual (TAU). The second group is a wait-list control in which participants receive only TAU. Patients and caregivers undergo a variety of interviews, tests, and behavioral observations throughout the study. Anxiety, depression, psychosocial stressors, manic symptoms, and children's experiences with psychotropic medications and with treatment or service providers are assessed. Caregivers, teachers, and family friends undergo interviews and make observations of the patient's level of support, general appearance and behavior, and overall functional capacity. The extent to which caregivers agree on the need for treatment and the extent of caregivers' knowledge of mood disorders is also assessed. Assessments occur at 3, 6, 12, 15, and 18 months after study enrollment. A comprehensive assessment is conducted at study entry and 1 year later. ;

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Treatment

Related Conditions & MeSH terms

Mood Disorders

Clinical Trial Details

NCT number	NCT00050557
Study type	Interventional
Source	Ohio State University
Contact
Status	Completed
Phase	Phase 1
Start date	July 2001
Completion date	December 2006

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT05321602` - Study to Evaluate the PK Profiles of LY03010 in Patients With Schizophrenia or Schizoaffective Disorder	Phase 1
Recruiting	`NCT05345392` - Brain, Emotions, and Mind-Wandering	N/A
Completed	`NCT05078450` - Mood Lifters Online for Graduate Students and Young Professionals	N/A
Not yet recruiting	`NCT04551027` - Assessing the Effect of Compensatory Cognitive Intervention Among People With Severe Mental Illness	N/A
Recruiting	`NCT03088657` - Design and Methods of the Mood Disorder Cohort Research Consortium (MDCRC) Study
Active, not recruiting	`NCT02542475` - Low Field Magnetic Stimulation: Open Label Study.	Phase 1/Phase 2
Completed	`NCT00916552` - Effects of Erythropoietin on Depressive Symptoms and Neurocognitive Deficits in Depression and Bipolar Disorder	Phase 2
Completed	`NCT00202514` - Placebo Controlled Trial of Depakote ER in Alcohol Dependent Patients With Mood and/or Anxiety Symptoms	Phase 2/Phase 3
Completed	`NCT00217932` - Effectiveness of Divalproex Sodium (Depakote) in Treating Children With Temper Outbursts and Severe Mood Swings	Phase 2
Completed	`NCT00006517` - Clinical Trials of Three Non-Drug Treatments for Winter Depression (SAD)	N/A
Terminated	`NCT03898843` - Assisted Animal Therapy: ReAnimal	N/A
Active, not recruiting	`NCT04358900` - Unobtrusive Monitoring of Affective Symptoms and Cognition Using Keyboard Dynamics (UnMASCK)
Recruiting	`NCT06360562` - Reconnecting to Ourselves and Others in Virtual Meetings (ROOM)	N/A
Completed	`NCT05745103` - Optimizing Behavioral Healthcare Delivery Through Technology	N/A
Suspended	`NCT03715400` - Mobile Virtual Positive Experiences for Anhedonia	N/A
Enrolling by invitation	`NCT03736538` - Nitrous Oxide- Suicidal Ideation	Phase 1
Completed	`NCT04601545` - The Virtual Reality Therapy as a Pulmonary Rehabilitation Supporting Method	N/A
Completed	`NCT02566980` - Biological Triggers of Depression in Pregnancy
Completed	`NCT03743844` - Psychosocial Intervention for Women With Mood Disorders Seeking Treatment for Obesity	N/A
Completed	`NCT05211063` - Effects of CROCUVIS+® on Computer Vision Syndrome, Sleep and Mood Disorders	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.